RhumbLine Advisers’s The Oncology Institute TOI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Buy |
+85,231
| New | +$175K | ﹤0.01% | 3303 |
|
|
2024
Q3 | – | Sell |
-2,175
| Closed | -$1K | – | 4329 |
|
|
2024
Q2 | $1K | Hold |
2,175
| – | – | ﹤0.01% | 4244 |
|
|
2024
Q1 | $3.44K | Hold |
2,175
| – | – | ﹤0.01% | 4032 |
|
|
2023
Q4 | $4.44K | Hold |
2,175
| – | – | ﹤0.01% | 4004 |
|
|
2023
Q3 | $3.05K | Sell |
2,175
-10,037
| -82% | -$14.1K | ﹤0.01% | 4061 |
|
|
2023
Q2 | $6.72K | Sell |
12,212
-26,388
| -68% | -$14.5K | ﹤0.01% | 4032 |
|
|
2023
Q1 | $26K | Buy |
38,600
+1,818
| +5% | +$1.23K | ﹤0.01% | 2930 |
|
|
2022
Q4 | $61K | Buy |
36,782
+1,154
| +3% | +$1.91K | ﹤0.01% | 2945 |
|
|
2022
Q3 | $165K | Buy |
35,628
+13,141
| +58% | +$60.9K | ﹤0.01% | 2932 |
|
|
2022
Q2 | $114K | Buy |
+22,487
| New | +$114K | ﹤0.01% | 3023 |
|